Nervenheilkunde 2005; 24(01): 48-58
DOI: 10.1055/s-0038-1629880
Original Article
Schattauer GmbH

Repetitive Transkranielle Magnetstimulation

Konsensus zum therapeutischen Einsatz bei psychiatrischen ErkrankungenRepetetiv transcranial magnetic stimulationConsensus on the therapeutic use in psychiatric disorders
G. Hajak
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg (Direktor: Prof. H. E. Klein)
,
F. Padberg
2   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität München (Direktor: Prof. H.-J. Möller)
,
U. Herwig
3   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Zürich (Direktor: Prof. R. M. Nitsch)
,
G. W. Eschweiler
4   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Tübingen (Direktor: Prof. G. Buchkremer)
,
S. Cohrs
5   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Göttingen (Direktor: Prof. E. Rüther)
,
B. Langguth
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg (Direktor: Prof. H. E. Klein)
,
C. Schönfeldt-Lecuona
6   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Ulm (Direktor: Prof. M. Spitzer)
,
A. J. Fallgatter
7   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Würzburg (Direktor: Prof. H. Beckmann)
,
J. Höppner
8   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Rostock (Direktor: Prof. S. Herpertz)
,
C. Plewina
4   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Tübingen (Direktor: Prof. G. Buchkremer)
,
P. Eichhammer
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg (Direktor: Prof. H. E. Klein)
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Eingegangen am: 09. März 2004

angenommen mit Revision am: 24. Juni 2004

Publikationsdatum:
30. Januar 2018 (online)

Zusammenfassung

Die repetitive Transkranielle Magnetstimulation (rTMS) ist eine innovative Technologie, mit der nicht-invasiv neurobiologische, physiologische und psychologische Funktionen des Gehirns moduliert werden können. In Konferenzen deutscher TMS-Experten wurde, einem formalen Konsensusprozess folgend, das Nutzen/Risiko-Verhältnis der rTMS als therapeutische Technik für die Psychiatrie beurteilt. Die rTMS wurde als viel versprechendes und innovatives Verfahren beurteilt, dessen weitere Erforschung wünschenswert ist. Zurzeit erscheinen depressive Störungen unter der Vielzahl untersuchter Diagnosen als mögliche Hauptindikation einer rTMS-Behandlung. Die überwiegend medikamentös vorbehandelten und zum Teil therapieresistenten depressiven Patienten zeigten in den existierenden Studien ein positives Nutzen/Risiko-Profil im Sinne einer moderaten klinischen Verbesserung bei zugleich niedriger Nebenwirkungsrate. Die rTMS sollte grundsätzlich von in der Methode erfahrenen oder speziell ausgebildeten Ärzten durchgeführt werden. Die aktuellen Sicherheitsempfehlungen sind dabei zu berücksichtigen und ein engmaschiges Therapiemonitoring sollte erfolgen. Obwohl der wissenschaftliche Datenbestand zur rTMS stetig wächst, ist die Methode gegenwärtig noch als experimentelles Therapieverfahren einzuschätzen, das bislang noch weniger gut untersucht ist als vor einer Zulassung stehende Psychopharmaka.

Summary

Repetitive transcranial magnetic stimulation (rTMS) is a technology that allows non-invasive modulation of neurobiological, physiological and psychological functions. A conference of national rTMS experts in Germany has assessed benefit/risk aspects of rTMS as a therapeutic tool in psychiatry following a formal consensus process. rTMS has been rated as promising and innovative treatment technique, worth further exploration in controlled clinical settings. Depressive disorders appear to be the primary target for rTMS treatment within the variety of psychiatric disorders investigated to date. A moderate therapeutic efficacy together with few and modest side effects results in an overall positive benefit/risk ratio in the investigated pre-treated or treatmentresistant depressed patients. The clinical application of rTMS should be restricted to physicians experienced with rTMS or specially trained who follow safety guidelines and monitor patients closely. In spite of the growing body of evidence, rTMS is still an experimental technique and its efficacy and safety have been less substantially proven compared to pharmacological agents approved for the treatment of psychiatric disorders.

 
  • Literatur

  • 1 Anand S, Hotson J. Transcranial magnetic stimulation: neurophysiological applications and safety. Brain Cogn 2002; 50 (03) 366-86.
  • 2 Ardouin C. et al. Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46 (02) 217-23.
  • 3 Avery DH. et al. Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data. J Nerv Ment Dis 1999; 187 (02) 114-7.
  • 4 Belmaker RH. et al. Managing the risks of repetitive transcranial magnetic stimulation. CNS Spectrums 2003; 8: 489.
  • 5 Berman RM. et al. A randomised clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 2000; 47 (04) 332-7.
  • 6 Boutros NN. et al. Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression. Psychiatry Res 2002; 113 (03) 245-54.
  • 7 Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002; 5 (01) 73-103.
  • 8 Cohen E. et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry 1999; 67 (01) 129-30.
  • 9 Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, NJ: Erlbaum; 1988
  • 10 Conca A. et al. Transcranial magnetic stimulation: A novel antidepressive stategy?. Neuopsychobiology 1996; 34 (04) 204-7.
  • 11 Dolberg OT, Schreiber S, Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry 2001; 49 (05) 468-70.
  • 12 Eichhammer P. et al. Sleep deprivation in depression: Stabilizing antidepressant effects by repetitive transcranial magnetic stimulation. Life Sciences 2002; 70: 1-9.
  • 13 Eichhammer P. et al. Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus. A short case series. Biol Psychiatry 2003; 54: 862-65.
  • 14 Ella R. et al. Switch to mania after slow rTMS of the right prefrontal cortex. J Clin Psychiatry 2002; 63: 249.
  • 15 Eschweiler GW, Plewnia C, Bartels M. [Which patients with major depression benefit from prefrontal repetitive magnetic stimulation]. Fortschr Neurol Psychiatr 2001; 69 (09) 402-9.
  • 16 Eschweiler GW, Plewnia C, Wild B. Gemeinsamkeiten und Unterschiede der therapeutischen transkraniellen Magnetstimulation und der Elektrokrampftherapie. Nervenheilkunde 2003; 22 (04) 189-95.
  • 17 Eschweiler GW. et al. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res 2000; 99 (03) 161-72.
  • 18 Fitzgerald PB. et al. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 2003; 60 (10) 1002-8.
  • 19 Garcia-Toro M. et al. Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Dis 2001; a 64 (2-3): 271-5.
  • 20 Garcia-Toro M. et al. Prefrontal repetitive transcranial stimulation as add on treatment in depression. J Neurol Psychiat 2001; b 71 (04) 546-8.
  • 21 Garcia-Toro M. Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression. Br J Psychiatry 1999; 175: 491.
  • 22 George MS. et al. Vagus nerve stimulation therapy: a research update. Neurology 2002; 59 (Suppl. 04) S56-61.
  • 23 George MS. et al. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry 1999; 56 (04) 300-11.
  • 24 George MS. et al. Mechanisms and state of the art of transcranial magnetic stimulation. J ECT 2002; 18 (04) 170-81.
  • 25 George MS, Nahas Z, Kozol FA, Li X, Yamanaka K, Mishory A, Bohning DE. Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr 2003; 8 (07) 496-514.
  • 26 George MS, Nahas Z, Li X, Kozel FA, Anderson B, Yamanaka K, Chae JH, Foust MJ. Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS). Semin Clin Neuropsychiatry 2002; 7 (04) 293-304.
  • 27 George MS, Nahas Z, Lisanby SH, Schlaepfer T, Kozel FA, Greenberg BD. Transcranial magnetic stimulation. Neurosurg Clin N Am 2003; 14 (02) 283-301.
  • 28 George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, Arana GW, Risch SC, Ballenger JC. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000; 48 (10) 962-70.
  • 29 George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, Greenberg BD, Hallett M, Post RM. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry 1997; 154 (12) 1752-6.
  • 30 Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 2003; 160 (05) 835-45.
  • 31 Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003; 53 (04) 324-31.
  • 32 Gur E, Lerer B, Dremencov E, Newman ME. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport 2000; 11 (13) 2925-9.
  • 33 Hajak G, Marienhagen M, Langguth B, Frick U, Wiegand R, Eichhammer P. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: A combined treatment and neuroimaging study. Psychol Med 2004; 34: 1-7.
  • 34 Heller L, van Hulsteyn DB. Brain stimulation using electromagnetic sources: theoretical aspects. Biophysical Journal 1992; 63: 129-38.
  • 35 Herwig U, Lampe Y, Juengling FD, Wunderlich A, Walter H, Spitzer M, Schönfeldt-Lecuona C. Add-on rTMS for treatment of depression: A pilot study using stereotaxic coil-navigation according to PET data. J Psychiatric Res 2003; 37 (04) 267-75.
  • 36 Herwig U, Schönfeldt-Lecuona C, Wunderlich AP, von Tiesenhausen C, Thielscher A, Walter H, Spitzer M. The navigation of transcranial magnetic stimulation. Psychiatry Res 2001; 108 (02) 123-31.
  • 37 Herwig U, Spitzer M, Schönfeldt-Lecuona C. Hat die antidepressive TMS klinische Bedeutung? Zur Notwendigkeit einer multizentrischen Studie. Nervenheilkunde 2003; 22: 196-9.
  • 38 Hoffman RE, Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry 2002; 159 (07) 1093-102.
  • 39 Holden C. Future brightening for depression treatments. Science 2003; 302: 810-3.
  • 40 Höppner J, Schulz M, Irmisch G, Mau R, Schlafke D, Richter J. Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci 2003; 253 (02) 103-9.
  • 41 Ilmoniemi RJ, Ruohonen J, Karhu J. Transcranial magnetic stimulation - a new tool for functional imaging of the brain. Crit Rev Biomed Eng 1999; 27 (3-5): 241-84.
  • 42 Jalinous R. Technical and practical aspects of magnetic nerve stimulation. J Clin Neurophysiol 1991; 8 (01) 10-25.
  • 43 Kammer T, Beck S, Thielscher A, Laubis-Herrmann U, Topka H. Motor thresholds in humans: a transcranial magnetic stimulation study comparing different pulse waveforms, current directions and stimulator types. Clin Neurophysiol 2001; 112 (02) 250-8.
  • 44 Kammer T, Thielscher A. Physikalische und physiologische Grundlagen der transkraniellen Magnetstimulation. Nervenheilkunde 2003; 22: 168-76.
  • 45 Keck M, Welt T, Muller M, Erhardt A, Ohl F, Toschi N, Holsboer F, Sillaber I. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 2002; 43 (01) 101.
  • 46 Keck ME, Welt T, Erhardt A, Muller MB, Sillaber I. Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation – Fokus auf Dopamin und Vasopressin. Nervenheilkunde 2003; 22: 346-9.
  • 47 Keck ME. rTMS as treatment strategy in psychiatric disorders—neurobiological concepts. Suppl Clin Neurophysiol 2003; 56: 100-16.
  • 48 Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, Repella JD, Danielson AL, Willis MW, Benson BE, Speer AM, Osuch E, George MS, Post RM. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999; 46 (12) 1603-13.
  • 49 Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, Ben-Shachar D, Feinsod M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 1999; 56 (04) 315-20.
  • 50 Kolbinger HM, Höflich G, Hufnagel H, Möller HJ, Kasper S. Trancranial magnetic stimulation (TMS) in the treatment of depression – a pilot study. Human Psychopharmacology 1995; 10: 305-10.
  • 51 Kozel FA, George MS. Meta-Analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatric Pract 2002; 8: 270-5.
  • 52 Langguth B, Eichhammer P, Kharraz A, Wiegand R, Hajak G. Repetitive transkranielle Magnetstimulation (rTMS) bei Schizophrenie. Nervenheilkunde 2003; 22: 350-3.
  • 53 Langguth B, Eichhammer P, Wiegand R, Maenner P, Jacob P, Hajak G. Neuronavigated rTMS in a patient with chronic tinnitus. Effects of a four-weeks treatment. NeuroReport 2003; 4 (07) 977-80.
  • 54 Lisanby SH, Datto CJ, Szuba MP. ECT and TMS: past, present, and future. Depress Anxiety 2000; 12 (03) 115-7.
  • 55 Lisanby SH, Kinnunen LH, Crupain MJ. Applications of TMS to therapy in psychiatry. J Clin Neurophysiol 2002; 19 (04) 344-60.
  • 56 Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28 (10) 1852-65.
  • 57 Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA. Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001; 58 (03) 303-5.
  • 58 Loo C, Mitchell P, Sachdev P, McDarmont B, Parker G, Gandevia S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry 1999; 156 (06) 946-8.
  • 59 Loo C, Sachdev P, Elsayed H, McDarmont B, Mitchell P, Wilkinson M, Parker G, Gandevia S. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry 2001; 49 (07) 615-23.
  • 60 Manes F, Jorge R, Morcuende M, Yamada T, Paradiso S, Robinson RG. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr 2001; 13 (02) 225-31.
  • 61 Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002; 51 (04) 280-7.
  • 62 Marg E, Rudiak D. Phosphenes induced by magnetic stimulation over the occipital brain: description and probable site of stimulation. Optometry & Vision Science 1994; 71 (05) 301-11.
  • 63 Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, Gironell A. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev 2002; (02) CD003493.
  • 64 Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 2003; 182: 480-91.
  • 65 McNamara B, Ray JL, Arthurs OJ, Boniface S. Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychol Med 2001; 31 (07) 1141-6.
  • 66 Mosimann UP, Rihs TA, Engeler J, Fisch H, Schlaepfer TE. Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers. Psychiatry Res 2000; 94 (03) 251-6.
  • 67 Nahas Z, Bohning DE, Molloy MA, Oustz JA, Risch SC, George MS. Safety and feasibility of repetitive transcranial magnetic stimulation in the treatment of anxious depression in pregnancy: a case report. J Clin Psychiatry 1999; 60 (01) 50-2.
  • 68 Nahas Z, Kozel FA, Li X, Anderson B, George MS. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord 2003; 5 (01) 40-7.
  • 69 Nahas Z, Molloy MA, Hughes PL, Oliver NC, Arana GW, Risch SC, George MS. Repetitive transcranial magnetic stimulation: perspectives for application in the treatment of bipolar and unipolar disorders. Bipolar Disord 1999; 1 (02) 73-80.
  • 70 Nedjat S, Folkerts HW. Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe. J ECT 1999; 15 (02) 166-8.
  • 71 Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000; 527 (Pt 3): 633-9.
  • 72 Padberg F, Goldstein-Muller B, Zwanzger P, Moller HJ. Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS. Suppl Clin Neurophysiol 2003; 56: 406-32.
  • 73 Padberg F, Möller HJ. Repetitive transcranial magnetic stimulation: does it have potential in the treatment of depression?. CNS Drugs 2003; 17 (06) 383-403.
  • 74 Padberg F, Zinka B, Zwanzger P, Ella R, Rupprecht R, Keck M, Möller HJ. Präfrontale repetitive transkranielle Magnetstimulation in der Therapie depressiver Erkrankungen. Nervenheilkunde 2003; 22: 331-40.
  • 75 Padberg F, Zwanzger P, Keck ME, Kathmann N, Mikhaiel P, Ella R, Rupprecht P, Thoma H, Hampel H, Toschi N, Moller HJ. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology 2002; 27 (04) 638-45.
  • 76 Padberg F, Zwanzger P, Thoma H, Kathmann N, Haag C, Greenberg BD, Hampel H, Moller HJ. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res 1999; 88 (03) 163-71.
  • 77 Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348 (9022): 233-7.
  • 78 Pascual-Leone A, Valls-Sole J, Wassermann EM, Brasil-Neto J, Cohen LG, Hallett M. Effects of focal transcranial magnetic stimulation on simple reaction time to acoustic, visual and somatosensory stimuli. Brain 1992; 115 (Pt 4): 1045-59.
  • 79 Post RM, Kimbrell TA, McCann UD, Dunn RT, Osuch EA, Speer AM, Weiss SR. Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential. J ECT 1999; 15 (01) 39-59.
  • 80 Pridmore S, Belmaker R. Transcranial magnetic stimulation in the treatment of psychiatric disorders. Psychiatry Clin Neurosci 1999; 53 (05) 541-8.
  • 81 Pridmore S, Khan U, Rosa MA, George MS. Information for assistants of repeated transcranial magnetic stimulation. Int J Ment Health Nurs 2003; 12 (01) 22-9.
  • 82 Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lucking CH. et al. Noninvasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994; 91 (02) 79-92.
  • 83 Rothwell JC, Thompson PD, Day BL, Boyd S, Marsden CD. Stimulation of the human motor cortex through the scalp. Exp Physiol 1991; 76 (02) 159-200.
  • 84 Rudiak D, Marg E. Finding the depth of magnetic brain stimulation: a re-evaluation. Electroencephalogr Clin Neurophysiol 1994; 93 (05) 358-71.
  • 85 Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson Jr RK, Goodman RR. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001; 25 (05) 713-28.
  • 86 Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 1999; 15 (01) 5-26.
  • 87 Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 2003; 28 (02) 201-5.
  • 88 Schönfeldt-Lecuona C, Walter H, Connemann BJ, Kassubek J, Spitzer M, Herwig U. [Historical review and recent research trends of the antidepressant repetitive transcranial magnetic stimulation (rTMS)]. Fortschr Neurol Psychiatr 2002; 70 (10) 520-30.
  • 89 Siebner HR, Filipovic SR, Rowe JB, Cordivari C, Gerschlager W, Rothwell JC, Frackowiak RS, Bhatia KP. Patients with focal arm dystonia have increased sensitivity to slow-frequency repetitive TMS of the dorsal premotor cortex. Brain 2003; 12 (Pt 12): 2710-25.
  • 90 Speer AM, Willis MW, Herscovitch P, Daube-Witherspoon M, Shelton JR, Benson BE, Post RM, Wassermann EM. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: II. Effects of motor cortex rTMS. Biol Psychiatry 2003; 54 (08) 818-25.
  • 91 Speer AM, Willis MW, Herscovitch P, Daube-Witherspoon M, Shelton JR, Benson BE, Post RM, Wassermann EM. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studies with H2150 positron emission tomography: II. Effects of prefrontal cortex rTMS. Biol Psychiatry 2003; 54 (08) 826-32.
  • 92 Stewart LM, Walsh V, Rothwell JC. Motor and phosphene thresholds: a transcranial magnetic stimulation correlation study. Neuropsychologia 2001; 39 (04) 415-9.
  • 93 Stikhina NIa, Lyskov EB, Lomarev MP, Aleksanian ZA, Mikhailov VO, Medvedev SV. [Transcranial magnetic stimulation in neurotic depression]. Zh Nevrol Psikhiatr Im S S Korsakova 1999; 99 (10) 26-9.
  • 94 Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21 (15) RC157.
  • 95 Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 2003; 126 (Pt 12): 2609-15.
  • 96 Wang H, Wang X, Scheich H. LTD and LTP induced by transcranial magnetic stimulation in auditory cortex. Neuroreport 1996; 7 (02) 521-5.
  • 97 Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 2001; 112 (08) 1367-77.
  • 98 Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998; 108 (01) 1-16.
  • 99 Zwanzger P, Ella R, Keck ME, Rupprecht R, Padberg F. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 2002; 51 (07) 602-3.